Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
06/2004
06/03/2004WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity
06/03/2004US20040106613 For treating sickle cell disease and glaucoma.
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004DE10045599B4 Haarfärbemittel auf der Basis von 4-Nitro-2,1,3-benzoxadiazol-Derivaten und dessen Verwendung als Farbstoff zum Färben von Haaren Hair dyeing composition on the basis of 4-nitro-2,1,3-benzoxadiazole derivatives and its use as a dye for dyeing hair
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2502705A1 Aryl ureido derivatives and their medical use
06/02/2004CN1152107C Spiro compound and application as electric fluorescent material material thereof
06/02/2004CN1152024C Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and use as lipase inhibitors thereof
05/2004
05/27/2004WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors
05/27/2004WO2004043939A1 Amide compounds and methods of using the same
05/27/2004WO2004014881A3 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/26/2004EP0935691B1 Optical brightening agent
05/21/2004WO2004041913A1 Electroluminescent metallo-supramolecules with terpyridine-based groups
05/19/2004EP1420011A1 Compounds usefulfor treating allergic and inflammatory diseases
05/19/2004EP1419770A1 Apo ai expression accelerating agent
05/19/2004EP1263745B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
05/19/2004CN1496981A Cycloamine derivative and its use as medicine
05/19/2004CN1150175C Derivatives of 1,3,4-oxadiazolone
05/19/2004CN1150161C Non-steroidal ligands for estrogen receptor
05/18/2004US6737383 Such as n-(4-fluorophenyl)-n-(1-methylethyl)-4-(2-methyl-phenyl)-3,5-dioxo-1,2,4 -oxadiazolidine-2-carboxamide
05/13/2004US20040092598 Antiproliferative agnets; anticancer agents; skin disorders
05/13/2004US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
05/12/2004EP1417186A2 Heterocyclic aryl sulphonamides
05/12/2004EP1416931A1 Inhibitors of polyq-aggregation
05/12/2004EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity
05/12/2004CN1495175A Halogenated pyrimidine and its application for reducing parasite
05/12/2004CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy
05/12/2004CN1149204C 1-heterocycle substd. diarylamines
05/12/2004CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas
05/06/2004WO2004037248A2 Modulation of peroxisome proliferator activated receptors activity
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087650 Inhibitors of IMPDH enzyme
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
05/06/2004US20040086744 Luminance, high purity, low cost, and good thermal stability; as emitters for polymeric light-emitting diodes (PLEDs)
05/06/2004EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/05/2004CN1148361C Oxyiminoalkanoic acid derivatives
05/04/2004US6730677 Treating memory impairment; enhance excitatory synaptic activity in order to restore an imbalance between brain subregions, as in treatment of schizophrenia or schizophreniform behavior.
04/2004
04/29/2004WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof
04/29/2004WO2004016221A3 Sulfonamides as potassium channel blockers
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004CA2588083A1 Selective androgen receptor modulators and methods of use thereof
04/29/2004CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof
04/28/2004EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
04/28/2004EP1234819B1 Processes for production of oxadiazoline derivatives
04/27/2004US6726730 Hair dyes which are readily soluble in water and distinguished by uniform absorption behavior and high washing stability; enable dyeing under gentle and skin-compatible conditions
04/22/2004WO2004033652A2 Inhibitors of fatty acid amide hydrolase
04/22/2004US20040077867 Amine compounds, their production and use
04/22/2004CA2501575A1 Inhibitors of fatty acid amide hydrolase
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146683C Optical brightening agent
04/21/2004CN1146560C Substituted benzoylpyrazoles as herbicides
04/21/2004CN1146550C Halogenated pyrimidines and its application as method for reducing parasite
04/21/2004CN1146542C Benzamide derivatives and their use as cytokine inhibitors
04/15/2004WO2004020445A3 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
04/15/2004US20040072881 Dietetics; osteoporosis; muscular disorders
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072018 For use in electroluminescent material
04/14/2004EP1406898A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
04/14/2004EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin
04/13/2004US6720343 (((4-(3-thien-2-yl-1,2,4-oxadiazol-5-yl)phenyl)sulfonyl) amino)acetic acid, optionally substituted; selective matrix metalloprotease (mmp-2) inhibition; low protein binding, high blood concentration, no p-450 inhibition
04/13/2004US6720335 Sulfonamide inhibitors of aspartyl protease
04/08/2004US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
04/07/2004EP1405636A1 Function regulator for retinoid relative receptor
04/06/2004US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
04/06/2004CA2067381C Treatment of hiv infections and compounds useful therein
04/01/2004US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes
04/01/2004US20040063762 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
04/01/2004US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders
03/2004
03/31/2004EP1401801A1 Selective androgen receptor modulators and methods of use thereof
03/25/2004WO2003090680A3 Novel phenyl derivatives as inducers of apoptosis
03/25/2004US20040058917 Wound healing agents; antiscarring agents
03/24/2004EP1400526A2 ((cyclo)alkyl substituted)- gamma -aminobutyric acid derivatives (=Gaba analogues), their preparation and their use in the treatment of neurological disorders
03/24/2004EP1399429A1 1,3,4-oxadiazol-2-yl thioesters and their use for acylating 7-aminocephalosporins
03/24/2004EP1399423A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
03/24/2004EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/24/2004EP0904079B1 Antidiabetic agents
03/18/2004US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders
03/18/2004US20040053907 Cell adhesion inhibitors
03/18/2004US20040053890 Naphthalene derivatives
03/17/2004EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy
03/17/2004EP1397340A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
03/17/2004CN1482120A Process for preparing S,Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound
03/16/2004US6706744 Hypoglycemic agents; antidiabetic agents
03/16/2004US6706743 β3 adrenergic receptor agonists and uses thereof
03/11/2004WO2004020445A2 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
03/11/2004WO2004020393A1 Dibenzylamine compound and medicinal use thereof
03/11/2004WO2004002462A3 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
03/11/2004WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
03/11/2004WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040048863 Treating osteoarthritis or rheumatoid arthritis
03/10/2004CN1480455A 'Sqiqu site' ramification and its preparing method as well as its activity of anti asthma
03/04/2004WO2004018461A2 Antibacterial benzoic acid derivatives
03/04/2004WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 72